Cargando…
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
Compelling epidemiologic evidence indicates that obesity is associated with a high risk of human malignancies, including thyroid cancer. We previously demonstrated that a high fat diet (HFD) effectively induces the obese phenotype in a mouse model of aggressive follicular thyroid cancer (Thrb(PV/PV)...
Autores principales: | Park, Jeongwon, Kim, Won Gu, Zhao, Li, Enomoto, Keisuke, Willingham, Mark, Cheng, Sheue-Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085193/ https://www.ncbi.nlm.nih.gov/pubmed/27145454 http://dx.doi.org/10.18632/oncotarget.8989 |
Ejemplares similares
-
Oncogenic mutations of thyroid hormone receptor β
por: Park, Jeong Won, et al.
Publicado: (2015) -
Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer
por: Fozzatti, Laura, et al.
Publicado: (2013) -
Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation()()
por: Zhu, Xuguang, et al.
Publicado: (2014) -
Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
por: Zhu, Xuguang, et al.
Publicado: (2018) -
SUN-338 Inflammation Promotes Aggressive Thyroid Cancer Progression in a Mouse Model
por: Park, Sunmi, et al.
Publicado: (2019)